Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Diventiamo REALI: strumento di comunicazione sanitaria familiare nel trapianto di cellule staminali pediatriche e nella terapia cellulare

16 novembre 2026 aggiornato da: Washington University School of Medicine

Diventiamo REALI: una sperimentazione pilota di uno strumento di comunicazione sanitaria familiare nel trapianto di cellule staminali pediatriche e nella terapia cellulare

The investigators will conduct a pilot feasibility and efficacy trial of a newly developed family health communication tool (called Let's Get REAL) in increasing youth involvement in real-time stem cell transplant and cellular therapy decisions (SCTCT). The investigators will pilot the intervention among 24 youth and their parents, stratified by youth age (stratum 1, 8-12 years of age and stratum 2, 13-17 years of age).

Panoramica dello studio

Stato

Reclutamento

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Stimato)

60

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Contatto studio

  • Nome: Ginny L Schulz, Ph.D., RN, CPNP-PC
  • Numero di telefono: 314-454-6018
  • Email: schulz_g@wustl.edu

Luoghi di studio

    • Missouri
      • St Louis, Missouri, Stati Uniti, 63110
        • Reclutamento
        • Washington University School of Medicine
        • Sub-investigatore:
          • Shalini Shenoy, M.D.
        • Contatto:
          • Ginny L Schulz, Ph.D., RN, CPNP-PC
          • Numero di telefono: 314-454-6018
          • Email: schulz_g@wustl.edu
        • Investigatore principale:
          • Ginny L Schulz, Ph.D., RN, CPNP-PC
        • Sub-investigatore:
          • Amy McQueen, Ph.D.

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

8 anni e precedenti (Bambino, Adulto, Adulto più anziano)

Accetta volontari sani

No

Sessi ammissibili allo studio

Tutto

Descrizione

Inclusion Criteria Youth:

  • Children or adolescents 8-17 years of age referred for SCTCT.
  • Diagnosis of malignant or nonmalignant disorder.
  • Referred for any type of SCTCT. Autologous and allogeneic stem cell and cellular therapies are eligible.
  • Planning to meet with a provider to discuss SCTCT.
  • Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed assent document.
  • Must speak English and be cognitively able to participate.

Inclusion Criteria Parents:

  • Parent or guardian of a child 8-17 years of age with any diagnosis referred for any type of SCTCT. Diagnoses may include malignant and nonmalignant disorders. Autologous and allogeneic stem cell and cellular therapies are eligible. Parent or guardian is defined as an adult who usually cares for the youth and has authority to make medical decisions for them.
  • Must have the ability to understand and willingness to consent to participate after reviewing an IRB approved informed consent document.
  • Must speak English and be cognitively able to participate.

Exclusion Criteria Youth:

  • Active medical problems severe enough to preclude study participation at the time of recruitment.

    • Patients who are otherwise eligible, but whose primary transplant physician does not want them to participate in the study.
  • Lacks cognitive capacity to complete study activities, as determined by consenting professional.

Exclusion Criteria Parents:

  • Their youth referred for SCTCT does not assent to participate.

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Ricerca sui servizi sanitari
  • Assegnazione: Non randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Let's Get REAL family health communication tool: Patients (8-12 years of age)

Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation.

Family health communication tool

Sperimentale: Let's Get REAL family health communication tool: Patients (13-17 years of age)

Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation.

Family health communication tool

Sperimentale: Let's Get REAL family health communication tool: Parents

Patients and parent(s) will be given the Let's Get REAL family health communication tool to use up to one month prior to their SCTCT consultation visit. It is a guide for pediatric patients and their families to learn about and discuss SCTCT. Participants will complete demographic and baseline surveys prior to using the tool, and then additional surveys up to one month after SCTCT consultation visit and up to one month post-discharge from SCTCT. SCTCT consultation visits will be audio-recorded. Participants may also participate in an optional semi-structured interview up to 8 weeks after SCTCT consultation.

Family health communication tool

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Feasibility of intervention as measured by the Feasibility of Intervention questionnaire
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Acceptability of intervention as measured by the Acceptability of Intervention questionnaire
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Appropriateness of intervention as measured by the Intervention of Appropriateness questionnaire
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Feasibility of intervention as measured qualitatively
Lasso di tempo: Up to 8 weeks after SCTCT consultation (estimated to be week 16)

Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of feasibility content codes.

Up to 8 weeks after SCTCT consultation (estimated to be week 16)
Acceptability of intervention as measured qualitatively
Lasso di tempo: Up to 8 weeks after SCTCT consultation (estimated to be week 16)

Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of acceptability content codes.

Up to 8 weeks after SCTCT consultation (estimated to be week 16)
Appropriateness of intervention as measured qualitatively
Lasso di tempo: Up to 8 weeks after SCTCT consultation (estimated to be week 16)

Content analysis of open-ended survey responses and quotations from individual interviews. Will be collecting number of appropriateness content codes.

Up to 8 weeks after SCTCT consultation (estimated to be week 16)

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Numero di pazienti che hanno scelto SCTCT
Lasso di tempo: Fino a 4 settimane dopo la consultazione SCTCT (stimata alla settimana 8)
Fino a 4 settimane dopo la consultazione SCTCT (stimata alla settimana 8)
Difference in feasibility scores in those 8-12 years of age and those 13-17 years of age as measured by the Feasibility of Intervention questionnaire
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report feasibility of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater feasibility.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Difference in acceptability scores in those 8-12 years of age and those 13-17 years of age as measured by the Acceptability of Intervention questionnaire
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report acceptability of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater acceptability.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Difference in appropriateness scores in those 8-12 years of age and those 13-17 years of age as measured by the Intervention of Appropriateness questionnaire
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 4-item scale that youth and their parents report appropriateness of the intervention on a 5-point Likert scale ranging from 'Completely disagree' to Completely agree'. A higher score indicates greater appropriateness.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Perceived levels of decision-making involvement in youth 8-17 years of age and their parents as measured by the Decision Making Involvement Scale
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 30-item scale that youth and their parents report youth involvement behaviors in a decision related to their illness on a 4-point Likert scale ranging from 'A Little Bit' to 'A Lot'. The higher the subscale score (child seek, child express, parent seek, parent express, and joint/options), the more that behavior or type of involvement occurred in the decision making process.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Observed levels of decision-making involvement in youth 8-17 years of age and their parents
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

Number of utterance occurrences for the following: 1) who uttered (youth, parent), 2) was utterance prompted (yes/no), if so, by who, 3) type of utterance (questions, opinion, concern, other), and 4) content of utterance (prognosis, side effect, expectation).

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Change in youth-parent communication as measured by the Likert-type Parent-Adolescent Communication Scale
Lasso di tempo: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)

This is a 20-item scale that youth and parents report the degree of openness in family communication and the extent of problems with family communications on a 5-point Likert ranging from 'strongly disagree' to 'strongly agree'. A higher score on the degree of openness subscale indicates better communication between parent and adolescent. For extent of problems subscale, a higher score indicates more problems in the parent-child communication.

Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
Change in the level of youth's general anxiety as measured by the Likert-type PROMIS Anxiety 8a Short Form or parent proxy
Lasso di tempo: Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)

This is an 8-item scale that measures youth's general anxiety in those 8-17 years of age on a 5-point Likert scale ranging from 'never' to 'almost always'.

Up to 4 weeks prior to SCTCT consultation and up to 4 weeks after SCTCT consultation (estimated to be 8 weeks)
Level of decisional conflict as measured by the Likert-type Decisional Conflict Scale
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a 10-item scale that youth and parents report their personal uncertainty and decisional conflict related to a specific decision. We are using the question format as it is recommended for those with limited reading or response skills. They respond 'Yes', 'No, or 'Unsure'. A total decision conflict score ranges from 0 (no decisional conflict) to 100 (extremely high decision conflict). Higher scores on subscales uncertainty, informed, values clarity, and support reflect feeling extremely uncertain about the best choice, feeling extremely uninformed, feeling extremely unclear about personal values, and feeling extremely unsupported in decision making respectively.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Youth-parent congruence of youth decision making involvement as measured by two Likert type statements
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

Number of dyads that agree on these two statements measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot': 1)"I/my child should be involved in future talks about transplant" and 2) "I/my child wants to be involved in future talks about transplant".

Up to 4 weeks after SCTCT consultation (estimated to be week 8)
Satisfaction with the decision making involvement as measured by one Likert type statement
Lasso di tempo: Up to 4 weeks after SCTCT consultation (estimated to be week 8)

This is a one item statement, "I am satisfied with my/my child's involvement in the transplant decision making process", measured on a 4-point Likert scale ranging from 'Not at all' to 'A lot'. A higher score indicates more satisfaction.

Up to 4 weeks after SCTCT consultation (estimated to be week 8)

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Collaboratori

Investigatori

  • Investigatore principale: Ginny Schulz, Ph.D., RN, CPNP-PC, Washington University School of Medicine

Pubblicazioni e link utili

La persona responsabile dell'inserimento delle informazioni sullo studio fornisce volontariamente queste pubblicazioni. Questi possono riguardare qualsiasi cosa relativa allo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

26 novembre 2024

Completamento primario (Stimato)

31 agosto 2027

Completamento dello studio (Stimato)

31 agosto 2027

Date di iscrizione allo studio

Primo inviato

12 novembre 2024

Primo inviato che soddisfa i criteri di controllo qualità

12 novembre 2024

Primo Inserito (Effettivo)

14 novembre 2024

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

17 novembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

16 novembre 2026

Ultimo verificato

1 novembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • 202410119
  • K12CA167540 (Sovvenzione/contratto NIH degli Stati Uniti)

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .